General Information of the Compound
| Compound ID |
CP0192113
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-Methoxy-N-(3-phenyl-[1,2,4]thiadiazol-5-yl)-benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
331472-31-2
4-Methoxy-N-(3-phenyl-[1,2,4]thiadiazol-5-yl)-benzamide
4-methoxy-N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzamide
AC1LDIQV
AKOS000813206
BDBM50097423
CHEMBL305322
F3394-1093
LUF-5417
MCULE-5464374219
MolPort-000-646-916
SCHEMBL6942413
STL203008
VU0618369-1
Z275024144
ZINC26474
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H13N3O2S
|
||||||||||||||||||
| Molecular Weight |
311.366
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(cc1)C(=O)Nc1nc(ns1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H13N3O2S/c1-21-13-9-7-12(8-10-13)15(20)18-16-17-14(19-22-16)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18,19,20)
Show/Hide
|
||||||||||||||||||
| InChIKey |
RGVXOHBJCGPTQH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound